ERD

Analyzing the impact of phthalate and DINCH exposure on fetal growth in a cohort with repeated urine collection

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell lin...

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

Prenatal Exposure to Chemical Mixtures and Metabolic Syndrome Risk in Children

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

A KNIMEWorkflow to Assist the Analogue Identification for Read-Across, Applied to Aromatase Activity

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly ...

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

ReadEDTest: A tool to assess the readiness of in vitro test methods under development for identifying endocrine disrupto...

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolism in a 3D in vitro model of human liver.

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

Integrating -omics approaches into population-based studies of endocrine disrupting chemicals: A scoping review.

Project: OBERON

Updated at: 01-11-2024

Show more information

Project acronym OBERON

Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Endocrine Disrupting Chemicals: Current Understanding, New Testing Strategies and Future Research Needs

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Prenatal exposure to persistent organic pollutants and markers of obesity and cardiometabolic risk in Spanish adolescent...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Obesity I: Overview and molecular and biochemical mechanisms.

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

The Exposome and Toxicology: A Win–Win Collaboration

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoro...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Periodic Reporting for period 3 - OBERON (An integrative strategy of testing systems for identification of EDs related t...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Quantitative Structure-Activity Relationship Modeling of the Amplex Ultrared Assay to Predict Thyroperoxidase Inhibitory...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Placental transfer of xenobiotics in pregnancy physiologically-based pharmacokinetic models: Structure and data

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Report on functional specifications and system architecture of OBERON IDM

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Website, logo and communication tools

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

ELIXIR and Toxicology: a community in development

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Prenatal exposure to persistent organic pollutants and markers of obesity and cardiometabolic risk in Spanish adolescent...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

"""Parabens and antimicrobial compounds in conventional and “green” personal care products"""

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Obesity III: Obesogen assays: Limitations, strengths, and new directions.

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Public symposium

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Demonstration of intra- and inter-laboratory reproducibility of ZOT used to evaluate EDs as obesogens

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opp...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Report on exposure levels of the ten selected EDs in Europe taking data from biomonitoring studies and birth cohorts

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders—An Int...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways develo...

Project: OBERON

Updated at: 30-11-2023

Show more information

Project acronym OBERON

Resources

Selected filters:

Analyzing the impact of phthalate and DINCH exposure on fetal growth in a cohort with repeated urine collection

Assessment of endocrine disruptor impacts on lipid metabolism in a fatty acid-supplemented HepaRG human hepatic cell lin...

Prenatal Exposure to Chemical Mixtures and Metabolic Syndrome Risk in Children

A KNIMEWorkflow to Assist the Analogue Identification for Read-Across, Applied to Aromatase Activity

A New In Vivo Zebrafish Bioassay Evaluating Liver Steatosis Identifies DDE as a Steatogenic Endocrine Disruptor, Partly ...

ReadEDTest: A tool to assess the readiness of in vitro test methods under development for identifying endocrine disrupto...

Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolism in a 3D in vitro model of human liver.

Integrating -omics approaches into population-based studies of endocrine disrupting chemicals: A scoping review.

Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach

Endocrine Disrupting Chemicals: Current Understanding, New Testing Strategies and Future Research Needs

Prenatal exposure to persistent organic pollutants and markers of obesity and cardiometabolic risk in Spanish adolescent...

Obesity I: Overview and molecular and biochemical mechanisms.

The Exposome and Toxicology: A Win–Win Collaboration

Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoro...

Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors

Periodic Reporting for period 3 - OBERON (An integrative strategy of testing systems for identification of EDs related t...

Quantitative Structure-Activity Relationship Modeling of the Amplex Ultrared Assay to Predict Thyroperoxidase Inhibitory...

Placental transfer of xenobiotics in pregnancy physiologically-based pharmacokinetic models: Structure and data

Report on functional specifications and system architecture of OBERON IDM

Website, logo and communication tools

ELIXIR and Toxicology: a community in development

Prenatal exposure to persistent organic pollutants and markers of obesity and cardiometabolic risk in Spanish adolescent...

"""Parabens and antimicrobial compounds in conventional and “green” personal care products"""

Obesity III: Obesogen assays: Limitations, strengths, and new directions.

Public symposium

Demonstration of intra- and inter-laboratory reproducibility of ZOT used to evaluate EDs as obesogens

Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opp...

Report on exposure levels of the ten selected EDs in Europe taking data from biomonitoring studies and birth cohorts

Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders—An Int...

AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways develo...